Stop TB Partnership’s Coordinating Board Meets in DC

Today was the opening of the 2-day Stop TB Partnership’s Coordinating Board (CB) meeting in Washington, D.C. which included welcoming remarks by Dr. Rajiv Shah (Administrator, USAID), Ms. Lois Quam (Executive Director, GHI), and Dr. Howard Koh (Assistant Secretary, U.S. Depart. of HHS). Having the meeting in the capital of the U.S. has been a great advocacy opportunity to help reinforce the commitment of the U.S. Government and partners to allocating resources to tuberculosis. During the days preceding the CB meeting, several high level missions were organized with heads of U.S. agencies and the esteemed Ministers of Health from South Africa, Lesotho, and Swaziland.

The board meets biannually to provide leadership and direction, to monitor the implementation of agreed policies, to plan activities of the Partnership, and to ensure coordination among Stop TB Partnership components. The Working Group on New Drugs is represented on the board.

Links to related news:

Southern African “A-Team” takes on TB

India: As the middle class rises, so does tuberculosis

SA nursing still plagued by many challenges

Motsoaledi forms partnership with American agencies

More funding for TB research and development needed, new report says

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...